KLK3 and Familial prostate cancer: Trials suggest that 20–50% of men diagnosed with prostate cancer due to PSA testing may be “over-diagnosed,” meaning their disease would have remained asymptomatic throughout their lifetimes and the treatment they underwent was thus unnecessary [49].